ONPATTRO® (patisiran)
View Prescribing InformationExplore clinical and educational resources related to the use of vutrisiran in adult patients with polyneuropathy of ATTRv (also known as hATTR) amyloidosis or with cardiomyopathy of wild-type or ATTRv amyloidosis
Resources
APOLLO Post-Hoc Analysis by Baseline Polyneuropathy Severity
Slide Presentation
A post-hoc analysis of the APOLLO trial was performed to evaluate the use of patisiran compared to placebo by baseline NIS quartile in patients with the polyneuropathy of hATTR. This infographic summarises the post-hoc analysis results, which were published in the journal Amyloid.
